Rhinitis in Patients Treated with a Combination of an mTOR Inhibitor and an EGFR Inhibitor

Publisher： Karger

E-ISSN： 2296-5262|33|7|401-402

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.7, 2010-06, pp. : 401-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Rechallenge with mTOR Inhibitors in Metastatic Renal Cell Carcinoma Patients Who Progressed on Previous mTOR Inhibitor Therapy

By  

Oncology, Vol. 85, Iss. 1, 2013-06 ,pp. : 8-13

Karger

Access to resources Recommend Favorite

Synergistic effects of histone deacetylase inhibitor in combination with mTOR inhibitor in the treatment of prostate carcinoma

By            

International Journal of Molecular Medicine, Vol. 31, Iss. 2, 2013-01 ,pp. : 339-346

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of Sunitinib Re-Exposure after Failure of an mTOR Inhibitor in Patients with Metastatic RCC

By  

Oncology Research and Treatment, Vol. 34, Iss. 6, 2011-05 ,pp. : 310-314

Karger

Access to resources Recommend Favorite

Phase Ib trial of the PI3K/mTOR inhibitor voxtalisib (SAR245409) in combination with chemoimmunotherapy in patients with relapsed or refractory B‐cell malignancies

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 175, Iss. 1, 2016-10 ,pp. : 55-65

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mammalian target of rapamycin (mTOR) inhibitor‐associated non‐infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 376-382

John Wiley & Sons Inc

Access to resources Recommend Favorite